Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Nasal Gel vs Spray in Adult Allergic Rhinitis
NCT02953379Phase 3Withdrawn
- Sponsor
- EMS
- Start
- May 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of mometasone furoate nasal spray in allergic rhinitis (AR), sponsored by EMS. Planned start May 2019; status: withdrawn.
02
Drugs
mometasone furoate nasal spray
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02953379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02953379.